In addition, MDSCs have been demonstrated to be populated in residual tumor tissues of HCC after insufficient radiofrequency ablation (iRFA), and compensatory upregulation of PD-L1 on residual MDSCs could be achieved during combination therapy with iRFA and MDSC inhibition. This evidence concerns the gene CD274 and neoplasm.